Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 4 studies | 21% ± 2% | |
oligodendrocyte | 4 studies | 22% ± 7% | |
glutamatergic neuron | 3 studies | 27% ± 10% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 23% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 5966.72 | 652 / 653 | 99% | 49.13 | 597 / 605 |
pancreas | 100% | 1813.26 | 328 / 328 | 98% | 30.96 | 175 / 178 |
prostate | 97% | 6706.50 | 238 / 245 | 100% | 233.70 | 501 / 502 |
kidney | 100% | 2659.60 | 89 / 89 | 94% | 37.70 | 844 / 901 |
liver | 100% | 2449.46 | 226 / 226 | 94% | 33.53 | 380 / 406 |
breast | 96% | 1458.41 | 440 / 459 | 96% | 49.38 | 1070 / 1118 |
intestine | 95% | 1837.69 | 915 / 966 | 96% | 54.87 | 508 / 527 |
stomach | 96% | 1696.72 | 344 / 359 | 92% | 39.99 | 263 / 286 |
brain | 99% | 2457.32 | 2624 / 2642 | 87% | 25.83 | 612 / 705 |
lung | 96% | 1096.69 | 554 / 578 | 79% | 21.63 | 914 / 1155 |
adrenal gland | 100% | 1973.00 | 258 / 258 | 75% | 14.65 | 172 / 230 |
esophagus | 92% | 767.77 | 1330 / 1445 | 82% | 17.64 | 150 / 183 |
ovary | 82% | 500.48 | 148 / 180 | 87% | 18.62 | 373 / 430 |
bladder | 62% | 830.57 | 13 / 21 | 91% | 45.34 | 457 / 504 |
uterus | 75% | 655.52 | 128 / 170 | 76% | 22.09 | 349 / 459 |
ureter | 0% | 0 | 0 / 0 | 100% | 24.38 | 1 / 1 |
adipose | 89% | 742.16 | 1070 / 1204 | 0% | 0 | 0 / 0 |
skin | 73% | 892.16 | 1316 / 1809 | 12% | 1.79 | 56 / 472 |
muscle | 82% | 588.33 | 657 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 78% | 16.33 | 35 / 45 |
spleen | 73% | 444.05 | 175 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 73% | 425.51 | 969 / 1335 | 0% | 0 | 0 / 0 |
heart | 38% | 223.11 | 323 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 30% | 4.12 | 24 / 80 |
peripheral blood | 21% | 128.50 | 199 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.92 | 1 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0052651 | Biological process | monoacylglycerol catabolic process |
GO_0045907 | Biological process | positive regulation of vasoconstriction |
GO_0019369 | Biological process | arachidonic acid metabolic process |
GO_0009062 | Biological process | fatty acid catabolic process |
GO_0031090 | Cellular component | organelle membrane |
GO_0005856 | Cellular component | cytoskeleton |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0004040 | Molecular function | amidase activity |
GO_0047372 | Molecular function | acylglycerol lipase activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
GO_0017064 | Molecular function | fatty acid amide hydrolase activity |
GO_0005543 | Molecular function | phospholipid binding |
Gene name | FAAH |
Protein name | Fatty-acid amide hydrolase 1 (EC 3.5.1.99) (Anandamide amidohydrolase 1) (Fatty acid ester hydrolase) (EC 3.1.1.-) (Oleamide hydrolase 1) Fatty acid amide hydrolase |
Synonyms | FAAH1 |
Description | FUNCTION: Catalyzes the hydrolysis of endogenous amidated lipids like the sleep-inducing lipid oleamide ((9Z)-octadecenamide), the endocannabinoid anandamide (N-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-ethanolamine), as well as other fatty amides, to their corresponding fatty acids, thereby regulating the signaling functions of these molecules . Hydrolyzes polyunsaturated substrate anandamide preferentially as compared to monounsaturated substrates . It can also catalyze the hydrolysis of the endocannabinoid 2-arachidonoylglycerol (2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-glycerol) . FAAH cooperates with PM20D1 in the hydrolysis of amino acid-conjugated fatty acids such as N-fatty acyl glycine and N-fatty acyl-L-serine, thereby acting as a physiological regulator of specific subsets of intracellular, but not of extracellular, N-fatty acyl amino acids (By similarity). . |
Accessions | O00519 A0A087WYA0 ENST00000243167.9 ENST00000484697.5 |